Literature DB >> 24679498

Primary prophylaxis of variceal bleeding.

Douglas A Simonetto1, Vijay H Shah1, Patrick S Kamath2.   

Abstract

Primary prevention of variceal bleeding is an important and long-debated topic in the management of patients with cirrhosis and esophageal varices. Prophylaxis is recommended for high-risk patients with small esophageal varices (advanced liver disease and/or presence of red wale marks) and those with medium/large varices. Nonselective β-blockers and endoscopic band ligation have been shown to be equally effective in primary prevention of variceal bleeding and are the only currently recommended therapies. Controversy still exists, however, regarding which one of these strategies is preferred. This article reviews the established recommendations and recent advances in the prevention of first esophageal variceal bleeding.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Endoscopy; Gastrointestinal hemorrhage; Portal hypertension; β-blockers

Mesh:

Substances:

Year:  2014        PMID: 24679498     DOI: 10.1016/j.cld.2013.12.005

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  4 in total

1.  Emergency treatment of esophageal varix incarceration in the endoscope and ligation device during endoscopic variceal rubber band ligation.

Authors:  Hong Zhao; Jilin Cheng; Yahong Xu; Cuili Lu; Shaoping Huang; Zhenyu Fan; Yuxin Shi
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  Prophylactic blood product transfusions in post-endoscopic band ligation bleeding - 'tag in TEG'.

Authors:  Sanchit Sharma; Ashish Chauhan
Journal:  JHEP Rep       Date:  2021-11-18

Review 3.  Prevention of portal hypertension: from variceal development to clinical decompensation.

Authors:  Julio D Vorobioff; Roberto J Groszmann
Journal:  Hepatology       Date:  2014-09-26       Impact factor: 17.425

4.  Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis.

Authors:  Beom Hee Kim; Jung Wha Chung; Chung Seop Lee; Eun Sun Jang; Sook-Hyang Jeong; Nayoung Kim; Jin-Wook Kim
Journal:  Korean J Intern Med       Date:  2019-02-18       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.